Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant
- PMID: 37628566
- PMCID: PMC10453904
- DOI: 10.3390/genes14081514
Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant
Abstract
Aim: Smith-Magenis syndrome (SMS) is a rare genetic neurodevelopmental disorder caused by a 17p11.2 deletion or pathogenic variant in the RAI1 gene. SMS is associated with developmental delay, intellectual disability (ID), and major sleep and behavioral disturbances. To explore how genetic variants may affect intellectual functioning and behavior, we compared intellectual and behavioral phenotypes between individuals with a 17p11.2 deletion and pathogenic RAI1 variant.
Method: We reviewed available clinical records from individuals (aged 0-45 years) with SMS, ascertained through a Dutch multidisciplinary SMS specialty clinic.
Results: We included a total of 66 individuals (n = 47, 71.2% with a 17p11.2 deletion and n = 19, 28.8% with a pathogenic RAI1 variant) for whom data were available on intellectual functioning, severity of ID (n = 53), and behavioral problems assessed with the Child Behavior Checklist (CBCL, n = 39). Median full-scale IQ scores were lower (56.0 vs. 73.5, p = 0.001) and the proportion of individuals with more severe ID was higher (p = 0.01) in the 17p11.2 deletion group. Median total CBCL 6-18 scores (73.5 vs. 66.0, p = 0.02) and scores on the sub-scales somatic complaints (68.0 vs. 57.0, p = 0.001), withdrawn/depressed behavior (69.5 vs. 55.0, p = 0.02), and internalizing behavior (66.0 vs. 55.0, p = 0.002) were higher in the RAI1 group.
Conclusion: The results of this study suggest that 17p11.2 deletions are associated with a lower level of intellectual functioning and less internalizing of problems compared to pathogenic RAI1 variants. The findings of this study may contribute to personalized-management strategies in individuals with SMS.
Keywords: 17p11.2 deletion; Smith–Magenis syndrome; behavioral problems; intellectual disability; pathogenic RAI1 variant; rare disorders.
Conflict of interest statement
The authors have declared no conflict of interest.
Figures


Similar articles
-
Smith-Magenis Syndrome.2001 Oct 22 [updated 2025 May 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2001 Oct 22 [updated 2025 May 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301487 Free Books & Documents. Review.
-
Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.Genes (Basel). 2022 Feb 11;13(2):335. doi: 10.3390/genes13020335. Genes (Basel). 2022. PMID: 35205380 Free PMC article. Review.
-
Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.Eur J Hum Genet. 2012 Feb;20(2):148-54. doi: 10.1038/ejhg.2011.167. Epub 2011 Sep 7. Eur J Hum Genet. 2012. PMID: 21897445 Free PMC article.
-
Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.Genet Med. 2006 Jul;8(7):417-27. doi: 10.1097/01.gim.0000228215.32110.89. Genet Med. 2006. PMID: 16845274
-
Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant.Am J Med Genet A. 2016 Sep;170(9):2383-8. doi: 10.1002/ajmg.a.37602. Epub 2016 Jun 17. Am J Med Genet A. 2016. PMID: 27311559 Free PMC article.
Cited by
-
Identification of Smith-Magenis syndrome cases through an experimental evaluation of machine learning methods.Front Comput Neurosci. 2024 Mar 22;18:1357607. doi: 10.3389/fncom.2024.1357607. eCollection 2024. Front Comput Neurosci. 2024. PMID: 38585279 Free PMC article.
-
Nonrecurrent 17p duplications in two patients with developmental and neurological abnormalities.Hum Genome Var. 2025 Mar 26;12(1):6. doi: 10.1038/s41439-025-00310-6. Hum Genome Var. 2025. PMID: 40140366 Free PMC article.
References
-
- Greenberg F., Guzzetta V., Montes de Oca-Luna R.M., Magenis R.E., Smith A.C.M., Richter S.F., Kondo I., Dobyns W.B., Patel P.I., Lupski J.R. Molecular Analysis of the Smith-Magenis Syndrome: A Possible Contiguous-Gene Syndrome Associated with del(17)(p11.2) Am. J. Hum. Genet. 1991;49:1207–1218. - PMC - PubMed
-
- Smith A.C.M., McGavran L., Waldstein G. Deletion of the 17 Short Arm in Two Patients with Facial Clefts. Am. J. Hum. Genet. 1982;34:A410.
-
- Finucane B., Haas-Givler B. Smith-Magenis Syndrome: Genetic Basis and Clinical Implications. J. Ment. Health Res. Intellect. Disabil. 2009;2:134–148. doi: 10.1080/19315860802627619. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous